Vaccine

Age at 1^st of doses for dose (mos.)

Primary series

Booster

Total number series

HbOC/PRP-T

HibTITER^TM

2-6

3 doses, 2mo. apart^a

1-15 mo.^bc

4

7-11

2 doses, 2mo. apart^a

12-18 mo.^bc

3

12-14

1 dose

15 mo.^bc

2

ActHib^eTM

OmniHib^TM

TETRAMUNE^TM

15-59

1 dose^d

None

1

PRP-OMP

PedvaxHIB^TM

2-6

2 doses, 2mo.apart^a

12 mo.^bc

3

7-11

2 doses, 2mo.apart^a

12-18 mo.^bc

3

12-14

1 dose

15 mo.^bc

2

15-59

1 dose^d

None

1

PRP-D

ProHIBIT^TM

15-59

1 dose^cd

None

1

^a

Minimally acceptable interval between doses is one month.

^b

At least 2 months after previous dose.

^c

After the primary infant Hib vaccine series is completed, any of the licensed Hib conjugate vaccines may be used as a booster dose.

^d

Children 15-59 months of age should receive only a single dose of Hib vaccine.

^e

Reconstituted with DTP as a combined DTP/Hib vaccine

^TM

Trademark

Note:  A DTP/Hib combination vaccine can be used in place of HbOC or PRP-T